Skip to content

A Study of Genetic Influence on LDL Hyper-responsiveness in Patients Following a Ketogenic Diet

Genetic Influence on LDL Hyper-responsiveness in Patients Following a Ketogenic Diet

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07137286
Enrollment
100
Registered
2025-08-22
Start date
2025-09-11
Completion date
2027-08-31
Last updated
2025-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

LDL Hyper-responsiveness

Brief summary

The purpose of this study is to identify whether individuals following a ketogenic diet who experience extreme LDL-C elevation, termed hyper-responders, have identifiable genetic variations in genes involved in cholesterol absorption.

Interventions

None listed

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of age or older * LDL-C \>170 mg/dL in response to starting a ketogenic diet

Exclusion criteria

* Patients who do not consent to blood draw for genetic testing * Those with LDL-C \<170 mg/dL on a ketogenic diet

Design outcomes

Primary

MeasureTime frameDescription
Number of Patients to have a genetic mutationBaselineGenetic Mutation will be defined as a mutation in ABCG5, ABCG8, APOB, APOE, CETP, CYP27A1, LDLR, LDLRAP1, LIPA, LPL, LRP6, and PCSK9 genes

Countries

United States

Contacts

Primary ContactSaad Omar
omar.saad@mayo.edu507-538-5162

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026